ArticleJournal of neuro-oncology2026

Clinical, molecular, and immunologic determinants of survival in WHO-defined IDH-wildtype glioblastoma treated with radiotherapy: a large real-world cohort study.

Cole Friedes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.